Skip to main content

Advertisement

Log in

Head and neck sarcoma: report of a case treated by intensity-modulated radiation therapy

  • Case Report
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

We report on a 71-year-old woman with parapharyngeal sarcoma. Surgery could not be performed because of the size and location of the tumor. After failure of four cycles of chemotherapy, intensity-modulated radiation therapy (IMRT) achieved complete clinical response and partial magnetic resonance imaging response (80%) at 24 months of follow-up. The results of radiotherapy, especially IMRT, for nonresectable head and neck soft tissue sarcoma are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Eeles RA, Fisher C, A’Hern RP et al (1993) Head and neck sarcomas: prognostic factors and implications for treatment. Br J Cancer 68:201–207

    CAS  PubMed  Google Scholar 

  2. Coindre JM, Terrier P, Bui NB et al (1996) Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French federation of cancer centers sarcoma group. J Clin Oncol 91:869–877

    Google Scholar 

  3. Freedman AM, Reiman HM, Woods JE (1989) Soft tissue sarcomas of the head and neck. Am J Surg 158(4):367–372

    Article  CAS  PubMed  Google Scholar 

  4. Tran LM, Mark R, Meier R et al (1992) Sarcomas of the head and neck. Prognosis factors and treatment strategies. Cancer 70:169–177

    Article  CAS  PubMed  Google Scholar 

  5. Fayda M, Aksu G, Yaman Agaoglu F et al (2009) The role of surgery and radiotherapy in treatment of soft tissue sarcomas of the head and neck region: review of 30 cases. J Craniomaxillofac Surg 37:42–48

    PubMed  Google Scholar 

  6. National Cancer Institute: Common terminology criteria for adverse events (CTCAE) Version 3.0. http://ctep.cancer.gov/forms/CTCAEv3.pdf

  7. Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247

    Article  CAS  PubMed  Google Scholar 

  8. Eilber FR, Eckardt J (1997) Surgical management of soft tissue sarcoma. Semin Oncol 24:526–533

    CAS  PubMed  Google Scholar 

  9. Bell RS, O’Sullivan B, Liu FF et al (1989) The surgical margin in soft-tissue sarcoma. J Bone Joint Surg Am 71:370–375

    CAS  PubMed  Google Scholar 

  10. Stojadinovic A, Leung DH, Hoos A et al (2002) Analysis of the prognostic significance of microscopic margins in 2084 localized primary adult soft tissue sarcomas. Ann Surg 235:424–434

    Article  PubMed  Google Scholar 

  11. Weber RS, Benjamin RS, Peters LJ et al (1986) Soft tissue sarcomas of the head and neck in adolescents and adults. Am J Surg 152:386–392

    Article  CAS  PubMed  Google Scholar 

  12. Clark MA, Fisher C, Judson I et al (2005) Soft tissue sarcomas in adults. N Engl J Med 353:701–711

    Article  CAS  PubMed  Google Scholar 

  13. Balm AJM, Coevorden F, Fletcher CDM et al (1995) Report of a symposium on diagnosis and treatment of adult soft tissue sarcomas of the head and neck. Eur J Surg Oncol 21:287–289

    Article  CAS  PubMed  Google Scholar 

  14. Simon MA, Enneking WF (1976) The management of soft-tissue sarcomas of the extremities. J Bone Joint Surg Am 58(3):317–327

    CAS  PubMed  Google Scholar 

  15. Parsons JT, Zlotecki RA, Reddy KA et al (2001) The role of radiotherapy and limb-conserving surgery in the management of soft-tissue sarcomas in adults. Hematol Oncol Clin N Am 15:377–388

    Article  CAS  Google Scholar 

  16. Enneking WF, Spanier SS, Goodman MA (1980) Current concepts review. The surgical staging of musculoskeletal sarcoma. J Bone Joint Surg 62:1027–1030

    CAS  PubMed  Google Scholar 

  17. Yang JC, Chang AE, Baker AR et al (1998) Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 16:197–203

    CAS  PubMed  Google Scholar 

  18. Pisters PW, Harrisson LB, Leung DH et al (1996) Long term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 14:859–868

    CAS  PubMed  Google Scholar 

  19. Delaney TF, Kepka L, Goldegerg SL et al (2007) Radiation therapy for control of soft tissue sarcomas resected with positive margins. Int J Radiat Oncol Biol Phys 67:1460–1469

    PubMed  Google Scholar 

  20. Gerrand CH, Bell RS, Wunder JS et al (2003) The influence of anatomic location on outcome in patients with soft tissue sarcoma of the extremity. Cancer 97:485–492

    Article  PubMed  Google Scholar 

  21. Mendenhall WM, Mendenhall CM, Werning JW et al (2005) Adult head and neck soft tissue sarcomas. Head Neck 27:916–922

    Article  PubMed  Google Scholar 

  22. Suit HD (1989) The role for radiation therapy in the management of patient with sarcoma of soft tissue. Cancer Treat Res 44:65–74

    CAS  PubMed  Google Scholar 

  23. Kraus DH, Dubner S, Harrison LB et al (1994) Prognostic factors for recurrence and survival in head and neck soft tissue sarcomas. Cancer 74:697–702

    Article  CAS  PubMed  Google Scholar 

  24. Willers H, Hug EB, Spiro IJ et al (2005) Adult soft tissue sarcomas of the head and neck treated by radiation and surgery or radiation alone: patterns of failure and prognostic factors. Int J Radiat Oncol Biol Phys 33:585–593

    Google Scholar 

  25. Le QT, Fu KK, Kroll S et al (1997) Prognostic factors in adult soft tissue sarcomas of the head and neck. Int J Radiat Oncol Biol Phys 37:975–984

    CAS  PubMed  Google Scholar 

  26. Barker JL, Paulino AC, Feeney S et al (2003) Locoregional treatment for adult soft tissue sarcomas of the head and neck: an institutional review. Cancer J 9:49–57

    Article  PubMed  Google Scholar 

  27. Zagars GK, Ballo MT (2003) Significance of dose in postoperative radiotherapy for soft tissue sarcoma. Int J Radiat Oncol Biol Phys 56:473–481

    Article  PubMed  Google Scholar 

  28. Bentz BG, Singh B, Woodruff J et al (2004) Head and neck soft tissue sarcomas: a multivariate analysis of outcomes. Ann Surg Oncol 11:619–628

    Article  PubMed  Google Scholar 

  29. Kepka L, Delaney TF, Suit HD et al (2005) Results of radiation therapy for unresected soft-tissue sarcomas. Int J Radiat Oncol Biol Phys 63:852–859

    PubMed  Google Scholar 

  30. Colville RJ, Charlton F, Kelly CG et al (2005) Multidisciplinary management of head and neck sarcomas. Head Neck 27:814–824

    Article  PubMed  Google Scholar 

  31. Chen SA, Morris CG, Amdur RJ et al (2005) Adult head and neck soft tissue sarcomas. Am J Clin Oncol 28:259–263

    Article  PubMed  Google Scholar 

  32. O’Sullivan B, Wylie J, Catton C et al (1999) The local management of soft tissue sarcoma. Semin Radiat Oncol 4:328–348

    Article  Google Scholar 

  33. Alektia KM, Hong L, Brennan MF et al (2007) Intensity modulated radiation therapy for primary soft tissue sarcoma of the extremity: preliminary results. Int J Radiat Oncol Biol Phys 68:458–464

    Google Scholar 

  34. Alektia KM, Brennan MF, Heley JH et al (2008) Impact of intensity-modulated radiation therapy on local control in primary soft tissue sarcoma of the extremity. J Clin Oncol 26:3440–3444

    Article  Google Scholar 

  35. Curtis AE, Okcu MF, Chintagumpala M (2009) Local control after intensity-modulated radiotherapy for head and neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 73:173–177

    PubMed  Google Scholar 

  36. Donaldson SS, Mesa J, Breneman JC et al (2001) Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma—a report from the IRSG. Int J Radiat Oncol Biol Phys 51:718–728

    CAS  PubMed  Google Scholar 

  37. Wharam MD, Meza J, Anderson J et al (2004) Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of Group III patients on the Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 22:1902–1908

    Article  PubMed  Google Scholar 

  38. Combs SE, Behnisch W, Kulozik AE et al (2007) Intensity modulated radiotherapy (IMRT) and fractionated stereotactic radiotherapy (FSRT) for children with head and neck rhabdomyosarcoma. BMC Cancer 7:177

    Article  PubMed  Google Scholar 

  39. DeMatelaere SL, Robert D, Burgess M et al (2008) Neoadjuvant chemotherapy-specific and overall treatment outcomes in patients with cutaneous angiosarcomas of the face with periorbital involvement. Head Neck J Sci 30:639–646

    Article  Google Scholar 

  40. Penel N, Bui BN, Bay JO et al (2008) Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX study. J Clin Oncol 26:5269–5274

    Article  CAS  PubMed  Google Scholar 

  41. Edmonson J (1994) Chemotherapeutic approaches to soft tissue sarcomas. Semin Surg Oncol 10:357–363

    Article  CAS  PubMed  Google Scholar 

  42. Sarcoma Meta-Analysis Collaboration (1997) Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet 350:1647–1654

    Article  Google Scholar 

  43. Wu Q, Mohan R, Morris M et al (2003) Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. I: dosimetric results. Int J Radiat Oncol Biol Phys 56:573–585

    Article  PubMed  Google Scholar 

  44. Mohan R, Wu Q, Manning M et al (2000) Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys 46:619–630

    CAS  PubMed  Google Scholar 

  45. Lauve A, Morris M, Schmidt-Ullrich R et al (2004) Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II—clinical results. Int J Radiat Oncol Biol Phys 60:374–387

    Article  PubMed  Google Scholar 

  46. Studer G, Huguenin PU, Davis JB et al (2006) IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients. Radiat Oncol 1:1–15

    Article  Google Scholar 

  47. Schwartz M, Vuong T, Ballivy O et al (2007) Accelerated radiotherapy with simultaneous integrated boost fractionation and intensity-modulated radiotherapy for advanced head and neck cancer. Otolaryngol Head Neck Surg 136:549–555

    Article  PubMed  Google Scholar 

  48. Weber DC, Rutz HP, Pedroni ES et al (2005) Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: the Paul Scherrer Institute experience. Int J Radiat Oncol Biol Phys 63(2):401–409

    PubMed  Google Scholar 

  49. Pommier P, Liebsch NJ, Deschler DG (2006) Proton beam radiation therapy for skull base adenoid cystic carcinoma. Arch Otolaryngol Head Neck Surg 132(11):1242–1249

    Article  PubMed  Google Scholar 

  50. Mizoe J, Tsujii H, Kamada T et al (2004) Dose escalation study of carbon ion radiotherapy for locally advanced head and neck cancer. Int J Radiat Oncol Biol Phys 60:358–364

    PubMed  Google Scholar 

  51. Tsujii H, Mizoe J, Kamada T et al (2007) Clinical results of carbon ion radiotherapy at NIRS. J Radiat Res 48:A1–A13

    Article  CAS  Google Scholar 

Download references

Conflict of interest statement

No author has any conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pierre Heudel.

About this article

Cite this article

Heudel, P., Biston, M.C., Fayette, J. et al. Head and neck sarcoma: report of a case treated by intensity-modulated radiation therapy. Int J Clin Oncol 15, 305–309 (2010). https://doi.org/10.1007/s10147-010-0037-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-010-0037-x

Keywords

Navigation